← Back to all trials
Enrolling By Invitation
NCT05629065
Pathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC)
Conditions: Breast Cancer, Gastrointestinal Cancer, Gynecologic Cancer, Thoracic Cancer, Genitourinary Cancer
Sex: All
Ages: 18 Years – N/A
Phase: NA
Enrollment: 800
Sponsor: Dana-Farber Cancer Institute
Location: United States
Summary
The purpose of this study is to increase serious illness conversations (SICs) about patients goals and preferences regarding their healthcare between patients with cancer and their oncology clinicians and improved care provided near the end of life.
Eligibility Criteria
Inclusion Criteria:Patients who are aged 18 years or older, reach one of the poor prognosis nodes identified and have an upcoming appointment at one of the following Dana Farber Cancer Institute oncology clinics (including Longwood and Chestnut Hill locations)Breast Oncology ClinicGastrointestinal Oncology ClinicGenitourinary Oncology ClinicGynecologic Oncology ClinicThoracic Oncology ClinicExclusion Criteria:Patients with an SIC documented in the Advance Care Planning module of the electronic health record in the 6 months prior to reaching a poor prognosis nodePatients who have previously been randomized in this trial (e.g., the patient is encountering a poor-prognosis node for the second time during the trial period)
Source: ClinicalTrials.gov (NCT05629065). StuddyBuddy aggregates publicly available trial information.
